Lacidipine
From Self-sufficiency
File:Lacidipine.png | |
Systematic (IUPAC) name | |
---|---|
3,5-diethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | |
Identifiers | |
CAS Number | 103890-78-4 |
ATC code | C08CA09 (WHO) |
PubChem | CID 5311217 |
Chemical data | |
Formula | C26H33NO6 |
Molar mass | 455.543 g/mol[[Script error: No such module "String".]] |
Lacidipine (tradenames Lacipil (GSK) or Motens (Boehringer Ingelheim)) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.
External links
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Carboxylate esters
- Pyridines
- Cardiovascular system drug stubs
- 2Fix